SB 203580盐酸盐
| 中文名称 | SB 203580盐酸盐 |
|---|---|
| 中文同义词 | 化合物 T21675;SB 203580盐酸盐;化合物 SB 203580 HYDROCHLORIDE;4-(4-(4-氟苯基)-2-(4-(甲基亚磺酰基)苯基)-1H-咪唑-5-基)吡啶盐酸盐;SB 203580 HYDROCHLORIDE,P38 MAPK抑制剂;SB 203580 hydrochloride (RWJ 64809 hydrochloride;SB203580 hydrochloride;SB-203580 hydrochloride) |
| 英文名称 | SB 203580 (hydrochloride) |
| 英文同义词 | RWJ 64809 hydrochloride;RWJ 64809 HYDROCHLORIDE;SB203580 HYDROCHLORIDE;SB-203580 HYDROCHLORIDE;SB 203580, Hydrochloride - CAS 869185-85-3 - Calbiochem;Adezmapimod (hydrochloride);Adezmapimod (SB-203580) hydrochloride;RWJ 64809 HCl;SB203580 HCl;SB 203580 hydrochloride, p38 MAPK inhibitor |
| CAS号 | 869185-85-3 |
| 分子式 | C21H17ClFN3OS |
| 分子量 | 413.9 |
| EINECS号 | |
| 相关类别 | |
| Mol文件 | 869185-85-3.mol |
| 结构式 | ![]() |
SB 203580盐酸盐 性质
| 储存条件 | -20C |
|---|---|
| 溶解度 | 不溶于乙醇;不溶于水; DMSO 中≥20.7 mg/mL |
| 形态 | 亮黄色固体 |
| 颜色 | 浅黄至黄色 |
| 水溶解性 | Soluble to 25 mM in water |
| 稳定性 | 吸湿性 |
| InChI | 1S/C21H16FN3OS.ClH/c1-27(26)18-8-4-16(5-9-18)21-24-19(14-2-6-17(22)7-3-14)20(25-21)15-10-12-23-13-11-15;/h2-13H,1H3,(H,24,25);1H |
| InChIKey | WOSGGXINSLMASH-UHFFFAOYSA-N |
| SMILES | Fc1ccc(cc1)c2[nH]c(nc2c4ccncc4)c3ccc(cc3)[S](=O)C.Cl |
|
p38 50 nM (IC 50 ) |
p38β2 500 nM (IC 50 ) |
SB 203580 (preincubated with 0-30 μM for 1 h and cultured for 24 h in the presence of 20 ng/mL IL-2) prevents the IL-2-induced proliferation of primary human T cells, murine CT6 T cells, or BAF F7 B cells with an IC
50
of 3-5 μM.
SB203580 blocks PKB phosphorylation (IC
50
3-5 μM). SB203580 inhibitsthe phosphorylation of Ser473 in a dose-dependent manner in both CT6 and activated human T cells and IL-2-responsive BA/F3 F7 B cells.
Cell Proliferation Assay
| Cell Line: | CT6, BA/F3 cell line F7, and PBMC/T cells |
| Concentration: | 0-30 μM |
| Incubation Time: | Preincubated with 0-30 μM SB203580 for 1 h and cultured for 24 h in the presence of 20 ng/mL IL-2 |
| Result: | Prevented the IL-2-induced proliferation of primary human T cells, murine CT6 T cells, or BAF F7 B cells with an IC 50 of 3-5 μM. |
Western Blot Analysis
| Cell Line: | CT6 cells, activated human T cells, and BA/F3 F7 cells |
| Concentration: | 0-30 μM |
| Incubation Time: | Preincubated with 0-30 μM SB203580 for 1 h before stimulating with 20 ng/mL IL-2 for 5 min |
| Result: | Inhibited the phosphorylation of PKB at Ser473 in a dose-dependent manner. |
SB203580 (5 mg/kg/day; intra peritoneal injected daily for 16 consecutive days, in female atymic Nu/Nu mice) treatment, p38WT tumors show a significantly smaller tumor burden when compared with p38TM tumors that were treated in parallel.
| Animal Model: | Six-week-old female atymic Nu/Nu mice CAL27 p38WT and p38TM tumors |
| Dosage: | 5 mg/kg/day |
| Administration: | Intra peritoneal injected daily for 16 consecutive days |
| Result: | After 2 weeks treatment, CAL27 p38WT tumors were significantly smaller; CAL27 p38TM tumors were not affected by the p38 inhibitor (n=10). |
安全信息
| WGK Germany | WGK 3 |
|---|---|
| 海关编码 | 2933399990 |
| 存储类别 | 11 - 可燃固体 |
| 危险性类别 | 急性毒性 类别4 经口 |
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2026/09/15 | HY-10256AR | SB 203580盐酸盐 Adezmapimod hydrochloride (Standard) | 869185-85-3 | 5 mg | 990元 |
| 2026/09/15 | HY-10256AR | SB 203580盐酸盐 Adezmapimod hydrochloride (Standard) | 869185-85-3 | 10 mg | 1485元 |
